154 related articles for article (PubMed ID: 8100486)
1. Protective effect of interferon beta on human T cell leukaemia virus type I infection of CD4+ T cells isolated from human cord blood.
Macchi B; Faraoni I; Mastino A; D'Onofrio C; Romeo G; Bonmassar E
Cancer Immunol Immunother; 1993 Jul; 37(2):97-104. PubMed ID: 8100486
[TBL] [Abstract][Full Text] [Related]
2. Combined treatments with interferon (alpha,beta) plus PGA1 to control early infection with HTLV-I in primary cord blood-derived mononuclear cells.
D'Onofrio C; Franzese O; Ricci F; Bonmassar E
Int J Immunopharmacol; 1993 Feb; 15(2):125-36. PubMed ID: 8468116
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of individual versus combined treatments with interferon alpha, beta and gamma on early infection with HTLV-I in vitro.
D'Onofrio C; Franzese O; Puglianiello A; Peci E; Lanzilli G; Bonmassar E
Int J Immunopharmacol; 1992 Aug; 14(6):1069-79. PubMed ID: 1428362
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood cultures.
D'Onofrio C; Pesce CD; Fontana T; Ciprani F; Bonmassar E; Caliŏ R
Cancer Immunol Immunother; 1990; 31(4):213-20. PubMed ID: 2116232
[TBL] [Abstract][Full Text] [Related]
5. Mononuclear cells from peripheral blood of adult donors and from cord blood are equally protected by alpha- and beta-interferons against infection with HTLV-I.
Macchi B; D'Onofrio C; Labianca RA; Bonmassar E
Pharmacol Res; 1990; 22(4):503-14. PubMed ID: 2205849
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).
Olière S; Hernandez E; Lézin A; Arguello M; Douville R; Nguyen TL; Olindo S; Panelatti G; Kazanji M; Wilkinson P; Sékaly RP; Césaire R; Hiscott J
PLoS Pathog; 2010 Nov; 6(11):e1001177. PubMed ID: 21079688
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection.
Melamed A; Laydon DJ; Al Khatib H; Rowan AG; Taylor GP; Bangham CR
Retrovirology; 2015 Nov; 12():91. PubMed ID: 26552867
[TBL] [Abstract][Full Text] [Related]
8. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
9. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.
Miyazato P; Yasunaga J; Taniguchi Y; Koyanagi Y; Mitsuya H; Matsuoka M
J Virol; 2006 Nov; 80(21):10683-91. PubMed ID: 16943297
[TBL] [Abstract][Full Text] [Related]
10. AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.
Macchi B; Faraoni I; Zhang J; Grelli S; Favalli C; Mastino A; Bonmassar E
J Gen Virol; 1997 May; 78 ( Pt 5)():1007-16. PubMed ID: 9152417
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous proliferation of memory (CD45RO+) and naive (CD45RO-) subsets of CD4 cells and CD8 cells in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II.
Prince HE; York J; Owen SM; Lal RB
Clin Exp Immunol; 1995 Nov; 102(2):256-61. PubMed ID: 7586675
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of human interferons on the immortalization of human, but not rabbit, T lymphocytes by human T-lymphotropic virus type-I (HTLV-I).
Oka T; Iwata J; Furihata M; Sonobe H; Miyoshi I; Ohtsuki Y
Int J Cancer; 1992 Jul; 51(6):915-20. PubMed ID: 1639539
[TBL] [Abstract][Full Text] [Related]
13. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Kagdi H; Demontis MA; Ramos JC; Taylor GP
PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.
Rizkallah G; Alais S; Futsch N; Tanaka Y; Journo C; Mahieux R; Dutartre H
PLoS Pathog; 2017 Apr; 13(4):e1006353. PubMed ID: 28426803
[TBL] [Abstract][Full Text] [Related]
15. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I.
Hanon E; Stinchcombe JC; Saito M; Asquith BE; Taylor GP; Tanaka Y; Weber JN; Griffiths GM; Bangham CR
Immunity; 2000 Nov; 13(5):657-64. PubMed ID: 11114378
[TBL] [Abstract][Full Text] [Related]
16. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative activity of cyclopentenone prostaglandins in early HTLV-1 infection is independent of IL-2 and is associated with HSP70 induction.
D'Onofrio C; Franzese O; De Marco A; Bonmassar E; Amici C
Leukemia; 1994 Jun; 8(6):1045-56. PubMed ID: 7516027
[TBL] [Abstract][Full Text] [Related]
18. Differential interference of alpha, beta or gamma interferons with HTLV-I integration and expression in vitro.
D'Onofrio C; Alvino E; Peci E; Caliò R; Bonmassar E
Ann Ist Super Sanita; 1991; 27(1):127-32. PubMed ID: 1958020
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
